Medizia OncoCare does not deal in retail sales and does not sell pharmaceutical products directly to individual consumers or patients.
Eligible business and institutional customers
We operate strictly on a Business-to-Business (B2B) model and supply pharmaceutical products only to eligible customers, including:
- Pharmaceutical companies and authorized distributors
- Hospitals and healthcare institutions
- Government and private organizations
- Licensed wholesalers and other authorized pharmaceutical businesses
- Third-party and contract manufacturing clients
Supply only against valid business documents
Pharmaceutical products are supplied only after verification of applicable business and regulatory documentation. This may include a valid Drug Licence, GST registration, company and business details, purchase documentation, billing or shipping information, and other documents required under applicable regulations.
Submission of an enquiry does not guarantee acceptance, manufacture, availability, or supply.
No direct-to-consumer (B2C) sales
Medizia OncoCare does not operate as a retail pharmacy or direct-to-consumer medicine seller. We do not intend to sell prescription pharmaceutical products directly to patients or the general public through this website.
Patients and consumers should consult an appropriately qualified healthcare professional regarding medicines, diagnosis, treatment, dosage, or other medical decisions.
Purpose of this website
This website provides information about pharmaceutical manufacturing, third-party manufacturing, contract manufacturing, institutional supply, packaging, branding, promotional support, and other B2B product capabilities.
Business model: B2B only
Retail sales: Not available
Direct patient or consumer sales: Not available
Supply: Only to eligible organizations and businesses, subject to documentation and regulatory compliance.